As of 2026-03-27, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 16.7x | 14.3x |
| Forward P/E multiples | 17.6x - 21.5x | 19.9x |
| Fair Price | (25.64) - (24.19) | (24.82) |
| Upside | -167.1% - -163.3% | -164.9% |
| Date | EV/EBITDA |